Papillary adenocarcinomas of the prostate. An immunohistochemical study
- 1 October 1984
- Vol. 54 (7), 1328-1332
- https://doi.org/10.1002/1097-0142(19841001)54:7<1328::aid-cncr2820540716>3.0.co;2-f
Abstract
Five cases of papillary adenocarcinomas of the prostate were studied for prostate-specific acid phosphatase, using the immunoperoxidase method, to determine the origin and histogenesis of these uncommon tumors. All five cases were prostatic-acid-phosphatase positive, whereas four cases showed in situ carcinoma involving large periurethral ducts. Positive immunohistochemical localization of prostate-specific acid phosphatase is useful in identifying papillary carcinoma of true prostatic origin and distinguishing them from prostatic-acid-phosphatase-negative carcinomas which may include tumors arising from periurethral glands or metaplastic urethral mucosa.This publication has 10 references indexed in Scilit:
- Mixed mucinous and papillary adenocarcinoma involving male urethra, probably originating in periurethral glandsCancer, 1981
- Prostatic mucinous carcinomaUrology, 1979
- “Endometrial” adenocarcinoma of the prostate.A distinctive tumor of probable prostatic duct originCancer, 1976
- Endometrial (papillary) carcinoma of the prostatic utricle—response to orchiectomy.A case reportCancer, 1973
- Prostatic adenocarcinoma of ductal originCancer, 1973
- Endometrial Carcinoma of Uterus Masculinus (Prostatic Utricle). Report of 6 CasesJournal of Urology, 1971
- Papillomatosis and Papillary Adenocarcinoma of Prostatic Ducts: A Case ReportJournal of Urology, 1970
- Endometrial carcinoma of prostatic utricle (uterus masculinus)Cancer, 1967
- Primary Carcinoma of the Male UrethraJournal of Urology, 1966